PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Beneficial or not beneficial: that is the question for IL-1 inhibition in atherosclerosis

2011-12-29
(Press-News.org) Atherosclerosis is a disease of the major arterial blood vessels. It is one of the major causes of heart attack and stroke. The proinflammatory molecule IL-1 has been linked to atherosclerosis and a clinical trial has been launched in which an antibody specific for IL-1-beta is being studied for its effects on the severe clinical complications of atherosclerosis (i.e., heart attack and stroke). However, a team of researchers led by Gary Owens, at the University of Virginia, Charlottesville, has now generated data in mice that raise potential concerns about this clinical trial — Owens and colleagues find that IL-1 limits the features of advanced atherosclerosis that are linked to the severe complications of the disease in humans.

### TITLE: Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice

AUTHOR CONTACT:
Gary Owens
University of Virginia, Charlottesville, VA, USA
Phone: 434.924.2652; E-mail: gko@virginia.edu.


ELSE PRESS RELEASES FROM THIS DATE:

JCI online early table of contents: Dec. 27, 2011

2011-12-29
EDITOR'S PICK Another potential obstacle to developing an HIV vaccine A clinical trial testing a candidate HIV vaccine known as the STEP study was halted in September 2007 after interim analysis indicated that the vaccine did not work. Moreover, subsequent analyses indicated that the vaccine made some individuals more susceptible to HIV, in particular individuals who had pre-existing immune effectors (antibodies) that recognized a component of the vaccine (adenovirus serotype 5 [Ad5]). A team of researchers led by Juliana McElrath, at the Fred Hutchinson Cancer Research ...

Tests for biomarker may help determine diagnosis of heart attack within hours

2011-12-29
CHICAGO – For patients admitted to an emergency department with chest pain, use of a contemporary or highly sensitive test for levels of troponin I (a protein in muscle tissue) may help rule-out a diagnosis of heart attack, while changes in the measured levels of this biomarker at 3 hours after admission may be useful to confirm a diagnosis of heart attack, according to a study in the December 28 issue of JAMA. One of the most common reasons patients seek care in an emergency department is for acute chest pain. "Early identification of individuals at high and intermediate ...

Perception of inappropriate care frequent among ICU workers

2011-12-29
CHICAGO – A survey of nurses and physicians in intensive care units (ICUs) in Europe and Israel indicated that the perception of inappropriate care, such as excess intensity of care for a patient, was common, and that these perceptions were associated with inadequate decision sharing, communication and job autonomy, according to a study in the December 28 issue of JAMA. "Clinicians perceive the care they provide as inappropriate when they feel that it clashes with their personal beliefs and/or professional knowledge. Intensive care unit workers who provide care perceived ...

Analysis does not support genetic test before use of anti-clotting drug

2011-12-29
CHICAGO – Although the U.S. Food and Drug Administration (FDA) has recommended that a certain type of genetic testing (for the genotype CYP2C19) be considered before prescribing the drug clopidogrel to identify individuals who may be less responsive to the medication, a review and analysis of previous studies did not find an overall significant association between the CYP2C19 genotype and cardiovascular events, according to a study in the December 28 issue of JAMA. Clopidogrel is an antiplatelet drug used by approximately 40 million patients worldwide to treat or prevent ...

Possible Defenses To A DUI Charge

2011-12-29
You are sitting in your car, watching the red lights in your rearview mirror. The officer exits their vehicle and begins walking toward your car. The next thing you know, you have been charged with a DUI. What do you do now? You may think you have no chance, that even though you did not feel intoxicated or impaired, the blood alcohol content reading of the breathalyzer showed you were over the limit, and you are as good as convicted. Machines don't make mistakes, do they? Challenging A DWI Charge While it may seem an open and shut case, there may be multiple ...

Oxidative DNA damage repair

2011-12-29
Oxidative stress is the cause of many serious diseases such as cancer, Alzheimer's, arteriosclerosis and diabetes. It occurs when the body is exposed to excessive amounts of electrically charged, aggressive oxygen compounds. These are normally produced during breathing and other metabolic processes, but also in the case of ongoing stress, exposure to UV light or X-rays. If the oxidative stress is too high, it overwhelms the body's natural defences. The aggressive oxygen compounds destroy genetic material, resulting in what are referred to as harmful 8-oxo-guanine base mutations ...

Irikaitz archaeological site -- host to a 25,000-year-old pendant

2011-12-29
The recent discovery of a pendant at the Irikaitz archaeological site in Zestoa (in the Basque province of Gipuzkoa) has given rise to intense debate: it may be as old as 25,000 years, which would make it the oldest found to date at open-air excavations throughout the whole of the Iberian Peninsula. This stone is nine centimetres long and has a hole for hanging it from the neck although it would seem that, apart from being adornment, it was used to sharpen tools. The discovery has had great repercussion, but it is not by any means the only one uncovered here by the team ...

Whistleblowing Remedies in New Jersey

2011-12-29
Recent decisions by the New Jersey Supreme Court and the Appellate Division clarify the definition of "adverse employment action" that triggers New Jersey's "whistleblower law," known as the Conscientious Employee Protection Act (CEPA). Adverse Employment Action John Seddon had worked for Dupont 30 years when he filed a complaint with OSHA, the federal office for occupational safety and health. Seddon's complaint involved DuPont's practice of inspecting employee vehicles at the gate of the plant. Employees had to stand by the side of a busy ...

Targeted blocking of cell death prevents fatal condition septic shock

2011-12-29
Ghent, Belgium 27 December 2011 - Researchers of VIB and UGent have discovered a new approach to preventing septic shock, an often fatal extreme inflammatory reaction of the body. It is the most frequent cause of death at intensive care departments in hospitals. In sepsis, acute inflammation is attended by low blood pressure and blood clots, causing the organs to stop working. Only recently, the Brazilian football legend Socrates, died of the consequences of this condition. In a new study in the top journal Immunity, Peter Vandenabeele and colleagues of VIB-UGent described ...

Toasting the chemistry of champagne: New Year's Eve video from the American Chemical Society

Toasting the chemistry of champagne: New Years Eve video from the American Chemical Society
2011-12-29
WASHINGTON, Dec. 27, 2011 — Just in time for those New Year's Eve toasts, which might include a farewell to the International Year of Chemistry, the world's largest scientific society today posted online a video on the chemistry of champagne. The latest addition to the award-winning Bytesize Science series from the American Chemical Society (ACS) is available at www.BytesizeScience.com. It explains that champagne, unlike other wines, undergoes a second fermentation in the bottle to trap carbon dioxide gas, which dissolves into the wine and forms the fabled bubbles in ...

LAST 30 PRESS RELEASES:

AI expert and industry leading toxicologist Thomas Hartung hails launch of agentic AI platform a “transformative moment” in chemical safety science

The RESIL-Card tool launches across Europe to strengthen cardiovascular care preparedness against crises

Tools to glimpse how “helicity” impacts matter and light

Smartphone app can help men last longer in bed

Longest recorded journey of a juvenile fisher to find new forest home

Indiana signs landmark education law to advance data science in schools

A new RNA therapy could help the heart repair itself

The dehumanization effect: New PSU research examines how abusive supervision impacts employee agency and burnout

New gel-based system allows bacteria to act as bioelectrical sensors

The power of photonics

From pioneer to leader: Alex Zhavoronkov chairs precision aging discussion and presents Luminary Award to OpenAI president at PMWC 2026

Bursting cancer-seeking microbubbles to deliver deadly drugs

In a South Carolina swamp, researchers uncover secrets of firefly synchrony

American Meteorological Society and partners issue statement on public availability of scientific evidence on climate change

How far will seniors go for a doctor visit? Often much farther than expected

Selfish sperm hijack genetic gatekeeper to kill healthy rivals

Excessive smartphone use associated with symptoms of eating disorder and body dissatisfaction in young people

‘Just-shoring’ puts justice at the center of critical minerals policy

A new method produces CAR-T cells to keep fighting disease longer

Scientists confirm existence of molecule long believed to occur in oxidation

The ghosts we see

ACC/AHA issue updated guideline for managing lipids, cholesterol

Targeting two flu proteins sharply reduces airborne spread

Heavy water expands energy potential of carbon nanotube yarns

AMS Science Preview: Mississippi River, ocean carbon storage, gender and floods

High-altitude survival gene may help reverse nerve damage

Spatially decoupling active-sites strategy proposed for efficient methanol synthesis from carbon dioxide

Recovery experiences of older adults and their caregivers after major elective noncardiac surgery

Geographic accessibility of deceased organ donor care units

How materials informatics aids photocatalyst design for hydrogen production

[Press-News.org] Beneficial or not beneficial: that is the question for IL-1 inhibition in atherosclerosis